Detalhe da pesquisa
1.
PROTAC therapy as a new targeted therapy for lung cancer.
Mol Ther
; 31(3): 647-656, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415148
2.
Delta-Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma.
Oncologist
; 25(9): 810-817, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32372416
3.
Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose.
Cancer Invest
; 36(5): 289-295, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30040495
4.
CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.
Proc Natl Acad Sci U S A
; 111(32): E3260-8, 2014 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25071166
5.
Silencing Receptor EphA2 Enhanced Sensitivity to Lipoplatin™ in Lung Tumor and MPM Cells.
Cancer Invest
; 34(7): 293-304, 2016 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27438907
6.
The landscape of somatic copy-number alteration across human cancers.
Nature
; 463(7283): 899-905, 2010 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20164920
7.
Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy.
Eur Arch Otorhinolaryngol
; 273(10): 3293-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26796877
8.
High-throughput oncogene mutation profiling in human cancer.
Nat Genet
; 39(3): 347-51, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17293865
9.
Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
Int J Cancer
; 135(1): 128-37, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347111
10.
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer.
Cells
; 13(6)2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534371
11.
PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer.
bioRxiv
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464204
12.
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032).
J Immunother Cancer
; 12(2)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316517
13.
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Nat Genet
; 33(2): 208-13, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12539049
14.
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background.
Oncogene
; 42(23): 1926-1939, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106126
15.
Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida.
Cancers (Basel)
; 15(21)2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958400
16.
Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice.
Cell Death Discov
; 9(1): 1, 2023 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588105
17.
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival.
JCI Insight
; 8(10)2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097751
18.
Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
BMC Cancer
; 12: 309, 2012 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22824143
19.
Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.
Cancer Cell
; 5(4): 341-51, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15093541
20.
Managing stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up.
Oral Oncol
; 128: 105854, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447565